Overcoming Financial Constraints of Ultrafiltration for Heart Failure

American Journal of Cardiology

Volumn 105, Issue 10, 2010, Pages 1504-1505

  Ross, Edward A ^a   Kazory, Amir ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; COST BENEFIT ANALYSIS; HEALTH CARE COST; HEART FAILURE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; LETTER; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RESOURCE MANAGEMENT;

COST-BENEFIT ANALYSIS; CRITICAL CARE; HEART FAILURE; HOSPITAL COSTS; HUMANS; NEEDS ASSESSMENT; ULTRAFILTRATION;

EID: 77951688443     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.01.338     Document Type: Letter

References (3)

1. Costanzo M.R., Guglin M.E., Saltzberg M.T., Jessup M.L., Bart B.A., Teerlink J.R., Jaski B.E., Fang J.C., Feller E.D., Haas G.J., Anderson A.S., Schollmeyer M.P., Sobotka P.A., and UNLOAD Trial Investigators. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49 (2007) 675-683
2. Bradley S.M., Levy W.C., and Veenstra D.L. Cost-consequences of ultrafiltration for acute heart failure: a decision model analysis. Circ Cardiovasc Qual Outcomes 2 (2009) 566-573
3. Kazory A., Ejaz A.A., and Ross E.A. Ultrafiltration for heart failure: how fast should we move?. Am Heart J 157 (2009) 205-207